| (State or other jurisdiction of incorporation) | (Commission File Number) | (I.R.S. Employer Identification Number) | ||||||
| Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425) | |||||
| Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) | |||||
| Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) | |||||
| Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) | |||||
| Title of each class | Trading Symbol(s) | Name of each exchange on which registered | ||||||||||||
Exhibit # | Description | |||||||
| 99 | ||||||||
| 104 | Cover Page Interactive Data File (the cover page XBRL tags are embedded within the Inline XBRL document). | |||||||
| Date: | July 23, 2026 | HONEYWELL INTERNATIONAL INC. | |||||||||||||||
By: /s/ Su Ping Lu | |||||||||||||||||
| Su Ping Lu | |||||||||||||||||
| Senior Vice President, General Counsel and Corporate Secretary | |||||||||||||||||

| Contacts: | |||||
| Media | Investor Relations | ||||
| Stacey Jones | Mark Macaluso | ||||
| (980) 378-6258 | (704) 627-6118 | ||||
| stacey.jones@honeywell.com | mark.macaluso@honeywell.com | ||||
| 2Q 2026 | 2Q 2025 | Change | ||||||||||||||||||
| Sales | $9,719 | $9,322 | 4% | |||||||||||||||||
Organic1 Growth | 4% | |||||||||||||||||||
| Operating Income | $1,737 | $1,843 | (6%) | |||||||||||||||||
| Operating Income Margin | 17.9% | 19.8% | (190 bps) | |||||||||||||||||
Segment Profit1 | $2,240 | $2,128 | 5% | |||||||||||||||||
Segment Margin1 | 23.1% | 22.8% | 30 bps | |||||||||||||||||
| Earnings Per Share - Continuing Operations | $17.83 | $4.33 | 312% | |||||||||||||||||
Adjusted Earnings Per Share1 | $4.52 | $4.72 | (4%) | |||||||||||||||||
| Cash Flow from Operations - Continuing Operations | $1,276 | $1,064 | 20% | |||||||||||||||||
Free Cash Flow1,4 | $1,252 | $878 | 43% | |||||||||||||||||
| 2Q 2026 | 2Q 2025 | Change | ||||||||||||||||||
| Sales | $5,187 | $5,018 | 3% | |||||||||||||||||
Organic1 Growth | 4% | |||||||||||||||||||
| Operating Income | $662 | $666 | (1%) | |||||||||||||||||
| Operating Income Margin | 12.8% | 13.3% | (50 bps) | |||||||||||||||||
Segment Profit1 | $985 | $904 | 9% | |||||||||||||||||
Segment Margin1 | 19.0% | 18.0% | 100 bps | |||||||||||||||||
| Earnings Per Share - Continuing Operations | $16.65 | $1.21 | 1,276% | |||||||||||||||||
Adjusted Earnings Per Share1 | $1.95 | $1.77 | 10% | |||||||||||||||||
| Cash Flow from Operations - Continuing Operations | $563 | $187 | 201% | |||||||||||||||||
Free Cash Flow1,4 | $456 | $114 | 300% | |||||||||||||||||
| BUILDING AUTOMATION | 2Q 2026 | 2Q 2025 | Change | |||||||||||||||||
| Sales | $2,002 | $1,826 | 10% | |||||||||||||||||
Organic1 Growth | 9% | |||||||||||||||||||
| Segment Profit | $542 | $479 | 13% | |||||||||||||||||
| Segment Margin | 27.1% | 26.2% | 90 bps | |||||||||||||||||
| PROCESS AUTOMATION AND TECHNOLOGY | ||||||||||||||||||||
| Sales | $1,679 | $1,613 | 4% | |||||||||||||||||
Organic1 Growth | (1%) | |||||||||||||||||||
| Segment Profit | $371 | $386 | (4%) | |||||||||||||||||
| Segment Margin | 22.1% | 23.9% | (180) bps | |||||||||||||||||
| INDUSTRIAL AUTOMATION | ||||||||||||||||||||
| Sales | $1,501 | $1,577 | (5%) | |||||||||||||||||
Organic1 Growth | 4% | |||||||||||||||||||
| Segment Profit | $258 | $257 | —% | |||||||||||||||||
| Segment Margin | 17.2% | 16.3% | 90 bps | |||||||||||||||||
| Previous Guidance | Current Guidance | |||||||
| Sales | $19.9B - $20.2B | $19.8B - $20.0B | ||||||
| Organic Growth | 2% - 3% | 3% - 4% | ||||||
Segment Margin2 | 19.8% - 20.3% | 20.1% - 20.5% | ||||||
| Expansion | Up 220 - 270 bps | Up 250 - 290 bps | ||||||
Adjusted Earnings Per Share2,3 | $7.90 - $8.30 | $8.05 - $8.35 | ||||||
Adjusted Earnings Growth3 | 22% - 28% | 25% - 29% | ||||||
| Operating Cash Flow | ~$2.1B | ~$2.1B | ||||||
Free Cash Flow4 | ~$2.0B | ~$2.0B | ||||||
| 1 | See additional information at the end of this release regarding non-GAAP financial measures. | |||||||
| 2 | Segment margin and adjusted EPS are non-GAAP financial measures. Management cannot reliably predict or estimate, without unreasonable effort, the impact and timing on future operating results arising from items excluded from segment margin and adjusted EPS. We therefore, do not present a guidance range, or a reconciliation to, the nearest GAAP financial measures of operating margin or EPS. | |||||||
| 3 | Adjusted EPS and adjusted EPS V% guidance excludes items identified in the non-GAAP reconciliation of adjusted EPS at the end of this release, and any potential future one-time items that we cannot reliably predict or estimate. | |||||||
| 4 | With respect to historical periods, free cash flow adjusts for capital expenditures, spin-off and separation-related cost payments, Resideo indemnification and reimbursement agreement termination payment, cash payment for settlement of the divestiture of asbestos liabilities, and cash flows attributable to Quantinuum. With respect to the company’s outlook for 2026, free cash flow adjusts for capital expenditures, spin-off and separation-related cost payments, and cash flows attributable to Quantinuum. | |||||||
| Three Months Ended June 30, | Six Months Ended June 30, | ||||||||||||||||||||||
| 2026 | 2025 | 2026 | 2025 | ||||||||||||||||||||
| Product sales | $ | 6,374 | $ | 6,177 | $ | 12,241 | $ | 11,984 | |||||||||||||||
| Service sales | 3,345 | 3,145 | 6,621 | 6,263 | |||||||||||||||||||
| Net sales | 9,719 | 9,322 | 18,862 | 18,247 | |||||||||||||||||||
| Costs, expenses and other | |||||||||||||||||||||||
| Cost of products sold | 4,205 | 3,947 | 8,068 | 7,670 | |||||||||||||||||||
| Cost of services sold | 1,861 | 1,711 | 3,602 | 3,451 | |||||||||||||||||||
| Total Cost of products and services sold | 6,066 | 5,658 | 11,670 | 11,121 | |||||||||||||||||||
| Research and development expenses | 524 | 459 | 1,016 | 875 | |||||||||||||||||||
| Selling, general and administrative expenses | 1,344 | 1,362 | 2,654 | 2,672 | |||||||||||||||||||
| Impairment of assets held for sale | 48 | — | 311 | 15 | |||||||||||||||||||
| Loss on debt extinguishment | 2 | — | 241 | — | |||||||||||||||||||
| Gain on deconsolidation of subsidiary | (6,629) | — | (6,629) | — | |||||||||||||||||||
| Other (income) expense | 472 | (113) | 465 | (342) | |||||||||||||||||||
| Interest and other financial charges | 363 | 329 | 719 | 614 | |||||||||||||||||||
| Total costs, expenses and other | 2,190 | 7,695 | 10,447 | 14,955 | |||||||||||||||||||
| Income from continuing operations before taxes and equity losses | 7,529 | 1,627 | 8,415 | 3,292 | |||||||||||||||||||
| Tax expense | 1,578 | 244 | 1,669 | 613 | |||||||||||||||||||
| Equity loss | 265 | — | 265 | — | |||||||||||||||||||
| Net income from continuing operations | 5,686 | 1,383 | 6,481 | 2,679 | |||||||||||||||||||
| Net income from discontinued operations | — | 186 | — | 357 | |||||||||||||||||||
| Net income | 5,686 | 1,569 | 6,481 | 3,036 | |||||||||||||||||||
| Less: Net (loss) income attributable to noncontrolling interest | 4 | (1) | (22) | 17 | |||||||||||||||||||
| Net income attributable to Honeywell Technologies | $ | 5,682 | $ | 1,570 | $ | 6,503 | $ | 3,019 | |||||||||||||||
| Earnings per share of common stock—basic: | |||||||||||||||||||||||
| Earnings per share of common stock from continuing operations—basic | $ | 17.92 | $ | 4.35 | $ | 20.50 | $ | 8.31 | |||||||||||||||
| Earnings per share of common stock from discontinued operations—basic | — | 0.57 | — | 1.08 | |||||||||||||||||||
| Total earnings per share of common stock—basic | $ | 17.92 | $ | 4.92 | $ | 20.50 | $ | 9.39 | |||||||||||||||
| Earnings per share of common stock—assuming dilution: | |||||||||||||||||||||||
| Earnings per share of common stock from continuing operations—assuming dilution | $ | 17.83 | $ | 4.33 | $ | 20.39 | $ | 8.26 | |||||||||||||||
| Earnings per share of common stock from discontinued operations—assuming dilution | — | 0.57 | — | 1.08 | |||||||||||||||||||
| Total earnings per share of common stock—assuming dilution | $ | 17.83 | $ | 4.90 | $ | 20.39 | $ | 9.34 | |||||||||||||||
| Weighted average number of shares outstanding - basic | 317.1 | 318.8 | 317.2 | 321.4 | |||||||||||||||||||
| Weighted average number of shares outstanding - assuming dilution | 318.6 | 320.5 | 319.0 | 323.2 | |||||||||||||||||||
| Three Months Ended June 30, | Six Months Ended June 30, | ||||||||||||||||||||||
| Net sales | 2026 | 2025 | 2026 | 2025 | |||||||||||||||||||
| Aerospace Technologies | $ | 4,532 | $ | 4,307 | $ | 8,854 | $ | 8,479 | |||||||||||||||
| Building Automation | 2,002 | 1,826 | 3,884 | 3,518 | |||||||||||||||||||
| Process Automation and Technology | 1,679 | 1,613 | 3,192 | 3,058 | |||||||||||||||||||
| Industrial Automation | 1,501 | 1,574 | 2,922 | 3,171 | |||||||||||||||||||
| Total Segment sales | 9,714 | 9,320 | 18,852 | 18,226 | |||||||||||||||||||
| Quantinuum | 5 | 2 | 10 | 21 | |||||||||||||||||||
| Total Net sales | $ | 9,719 | $ | 9,322 | $ | 18,862 | $ | 18,247 | |||||||||||||||
| Three Months Ended June 30, | Six Months Ended June 30, | ||||||||||||||||||||||
| Segment profit | 2026 | 2025 | 2026 | 2025 | |||||||||||||||||||
| Aerospace Technologies | $ | 1,126 | $ | 1,098 | $ | 2,270 | $ | 2,197 | |||||||||||||||
| Building Automation | 542 | 479 | 1,038 | 919 | |||||||||||||||||||
| Process Automation and Technology | 371 | 386 | 730 | 699 | |||||||||||||||||||
| Industrial Automation | 258 | 256 | 499 | 486 | |||||||||||||||||||
| Corporate and All Other | (57) | (91) | (105) | (144) | |||||||||||||||||||
| Total Segment profit | 2,240 | 2,128 | 4,432 | 4,157 | |||||||||||||||||||
| Interest and other financial charges | (363) | (329) | (719) | (614) | |||||||||||||||||||
Interest income1 | 79 | 79 | 169 | 170 | |||||||||||||||||||
Amortization of acquisition-related intangibles2 | (116) | (132) | (269) | (267) | |||||||||||||||||||
| Impairment of assets held for sale | (48) | — | (311) | (15) | |||||||||||||||||||
Stock compensation expense3 | (51) | (55) | (108) | (114) | |||||||||||||||||||
Pension ongoing income4 | 168 | 85 | 332 | 225 | |||||||||||||||||||
Other postretirement income4 | 2 | 4 | 4 | 8 | |||||||||||||||||||
Repositioning and other gains (charges)5 | (91) | (30) | (159) | (78) | |||||||||||||||||||
| Loss on debt extinguishment | (2) | — | (241) | — | |||||||||||||||||||
Divestiture-related costs6 | (820) | (56) | (1,134) | (67) | |||||||||||||||||||
| Gain on deconsolidation of subsidiary | 6,629 | — | 6,629 | — | |||||||||||||||||||
| Equity loss | (265) | — | (265) | — | |||||||||||||||||||
Other expense7 | (30) | (16) | (70) | (33) | |||||||||||||||||||
Quantinuum Loss8 | (68) | (51) | (140) | (80) | |||||||||||||||||||
| Income before taxes | $ | 7,264 | $ | 1,627 | $ | 8,150 | $ | 3,292 | |||||||||||||||
| 1 | Amounts included in Other (income) expense. | |||||||
| 2 | Amounts included in Cost of products and services sold. | |||||||
| 3 | Amounts included in Selling, general and administrative expenses. | |||||||
| 4 | Amounts included in Cost of products and services sold (service cost component), Selling, general and administrative expenses (service cost component), Research and development expenses (service cost component), and Other (income) expense (non-service cost component). | |||||||
| 5 | Amounts included in Cost of products and services sold, Selling, general and administrative expenses, repositioning, asbestos, and environmental gains (expenses). | |||||||
| 6 | Amounts included in Selling, general and administrative expenses, Research and development expenses, and Other (income) expense. | |||||||
| 7 | Amounts include the other components of Selling, general and administrative expenses and Other (income) expense not included within other categories in this reconciliation. Equity income of affiliated companies from strategically aligned investments is included in segment profit. | |||||||
| 8 | Includes consolidated losses of Quantinuum prior to the deconsolidation of the Company’s investment in Quantinuum, which does not meet the definition of an operating segment. Included in Net sales, Cost of products and services sold, Research and development expenses, Selling, general and administrative expenses, and Other (income) expense. | |||||||
| June 30, 2026 | December 31, 2025 | ||||||||||
| ASSETS | |||||||||||
| Current assets | |||||||||||
| Cash and cash equivalents | $ | 8,751 | $ | 12,487 | |||||||
| Short-term investments | 445 | 443 | |||||||||
Accounts receivable, less allowances of $172 and $202, respectively | 8,337 | 7,621 | |||||||||
| Inventories | 6,401 | 6,162 | |||||||||
| Assets held for sale | 2,366 | 2,492 | |||||||||
| Other current assets | 1,779 | 1,182 | |||||||||
| Total current assets | 28,079 | 30,387 | |||||||||
| Equity method investments | 7,459 | 206 | |||||||||
| Long-term receivables and other investments | 1,167 | 1,198 | |||||||||
| Property, plant and equipment—net | 4,594 | 4,629 | |||||||||
| Goodwill | 19,967 | 21,079 | |||||||||
| Other intangible assets—net | 6,413 | 6,736 | |||||||||
| Deferred income taxes | 199 | 199 | |||||||||
| Other assets | 9,466 | 9,247 | |||||||||
| Total assets | $ | 77,344 | $ | 73,681 | |||||||
| LIABILITIES | |||||||||||
| Current liabilities | |||||||||||
| Accounts payable | $ | 6,390 | $ | 6,315 | |||||||
| Commercial paper and other short-term borrowings | 2,478 | 5,893 | |||||||||
| Current maturities of long-term debt | 5,282 | 1,546 | |||||||||
| Accrued liabilities | 7,769 | 8,462 | |||||||||
| Liabilities held for sale | 1,275 | 1,198 | |||||||||
| Total current liabilities | 23,194 | 23,414 | |||||||||
| Long-term debt | 26,228 | 27,141 | |||||||||
| Deferred income taxes | 2,695 | 1,577 | |||||||||
| Postretirement benefit obligations other than pensions | 106 | 111 | |||||||||
| Other liabilities | 6,264 | 6,408 | |||||||||
| Shareowners' equity | 18,857 | 15,030 | |||||||||
Total liabilities and shareowners’ equity | $ | 77,344 | $ | 73,681 | |||||||
| Three Months Ended June 30, | Six Months Ended June 30, | ||||||||||||||||||||||
| 2026 | 2025 | 2026 | 2025 | ||||||||||||||||||||
| Cash flows from operating activities | |||||||||||||||||||||||
| Net income | $ | 5,686 | $ | 1,569 | $ | 6,481 | $ | 3,036 | |||||||||||||||
| Less: Net income from discontinued operations | — | 186 | — | 357 | |||||||||||||||||||
Net income from continuing operations | 5,686 | 1,383 | 6,481 | 2,679 | |||||||||||||||||||
Adjustments to reconcile net income from continuing operations to net cash (used for) provided by operating activities | |||||||||||||||||||||||
| Depreciation | 156 | 143 | 290 | 269 | |||||||||||||||||||
| Amortization | 156 | 205 | 379 | 404 | |||||||||||||||||||
| Gain on deconsolidation of subsidiary | (6,629) | — | (6,629) | — | |||||||||||||||||||
| Equity loss income of affiliated companies | 256 | (12) | 240 | (23) | |||||||||||||||||||
| (Gain) loss on sale of non-strategic businesses and assets | — | 30 | (6) | 29 | |||||||||||||||||||
| Impairment of assets held for sale | 48 | — | 311 | 15 | |||||||||||||||||||
Loss on debt extinguishment | 2 | — | 241 | — | |||||||||||||||||||
| Repositioning and other charges | 91 | 41 | 159 | 84 | |||||||||||||||||||
| Net payments for repositioning and other charges | (82) | (91) | (145) | (195) | |||||||||||||||||||
| Pension and other postretirement income | (169) | (89) | (336) | (233) | |||||||||||||||||||
| Pension and other postretirement benefit payments | (6) | (7) | (11) | (12) | |||||||||||||||||||
| Stock compensation expense | 51 | 55 | 108 | 114 | |||||||||||||||||||
| Deferred income taxes | 1,079 | (12) | 962 | (31) | |||||||||||||||||||
| Other | 203 | (107) | 252 | (317) | |||||||||||||||||||
| Changes in assets and liabilities, net of the effects of acquisitions and divestitures: | |||||||||||||||||||||||
| Accounts receivable | (271) | (429) | (718) | (853) | |||||||||||||||||||
| Inventories | (31) | (291) | (234) | (438) | |||||||||||||||||||
| Other current assets | (314) | (183) | (449) | (154) | |||||||||||||||||||
| Accounts payable | 378 | 244 | 89 | 112 | |||||||||||||||||||
| Accrued liabilities | 895 | 554 | 70 | 412 | |||||||||||||||||||
Income taxes | (223) | (370) | (428) | (420) | |||||||||||||||||||
| Net cash provided by operating activities from continuing operations | 1,276 | 1,064 | 626 | 1,442 | |||||||||||||||||||
| Net cash provided by operating activities from discontinued operations | — | 255 | — | 474 | |||||||||||||||||||
| Net cash provided by operating activities | 1,276 | 1,319 | 626 | 1,916 | |||||||||||||||||||
| Cash flows from investing activities | |||||||||||||||||||||||
| Capital expenditures | (315) | (226) | (538) | (416) | |||||||||||||||||||
| Increase in investments | (311) | (330) | (505) | (681) | |||||||||||||||||||
| Decrease in investments | 301 | 415 | 513 | 753 | |||||||||||||||||||
Receipts (payments) from settlements of derivative contracts | 42 | (290) | 127 | (415) | |||||||||||||||||||
| Cash paid for acquisitions, net of cash acquired | (23) | (2,158) | (28) | (2,163) | |||||||||||||||||||
| Deconsolidation of subsidiary cash | (623) | — | (623) | — | |||||||||||||||||||
| Proceeds from sale of business, net of cash transferred | — | 1,157 | 6 | 1,157 | |||||||||||||||||||
| Net cash used for investing activities from continuing operations | (929) | (1,432) | (1,048) | (1,765) | |||||||||||||||||||
| Net cash used for investing activities from discontinued operations | — | (77) | — | (115) | |||||||||||||||||||
| Net cash used for investing activities | (929) | (1,509) | (1,048) | (1,880) | |||||||||||||||||||
| Cash flows from financing activities | |||||||||||||||||||||||
| Proceeds from issuance of commercial paper and other short-term borrowings | 3,153 | 7,008 | 7,911 | 11,863 | |||||||||||||||||||
| Payments of commercial paper and other short-term borrowings | (5,306) | (6,577) | (11,324) | (9,990) | |||||||||||||||||||
| Proceeds from issuance of common stock | 29 | 56 | 199 | 98 | |||||||||||||||||||
| Proceeds from issuance of long-term debt | — | 3,989 | — | 4,035 | |||||||||||||||||||
| Payments of long-term debt | (582) | (1,265) | (13,187) | (1,309) | |||||||||||||||||||
| Repurchases of common stock | — | (1,702) | (1,000) | (3,604) | |||||||||||||||||||
| Cash dividends paid | (795) | (747) | (1,576) | (1,479) | |||||||||||||||||||
| Pre-separation funding | — | — | 15,835 | — | |||||||||||||||||||
| Other | (12) | (3) | (104) | (35) | |||||||||||||||||||
| Net cash provided by (used for) financing activities | (3,513) | 759 | (3,246) | (421) | |||||||||||||||||||
| Effect of foreign exchange rate changes on cash and cash equivalents | (60) | 123 | (68) | 167 | |||||||||||||||||||
Net decrease in cash and cash equivalents | (3,226) | 692 | (3,736) | (218) | |||||||||||||||||||
| Cash and cash equivalents at beginning of period | 11,977 | 9,657 | 12,487 | 10,567 | |||||||||||||||||||
| Cash and cash equivalents at end of period | $ | 8,751 | $ | 10,349 | $ | 8,751 | $ | 10,349 | |||||||||||||||
| Three Months Ended June 30, 2026 | |||||
| Honeywell | |||||
| Reported sales percent change | 4% | ||||
| Less: Impact of divestitures to the prior period | (2)% | ||||
| Reported sales percent change, adjusted for impact of divestitures | 6% | ||||
| Less: Foreign currency translation | 1% | ||||
| Less: Acquisitions | 1% | ||||
| Less: Other | —% | ||||
| Organic sales percent change | 4% | ||||
Less: Separation Adjustments1 | —% | ||||
| Organic sales percent change (Honeywell Technologies) | 4% | ||||
| Building Automation | |||||
| Reported sales percent change | 10% | ||||
| Less: Impact of divestitures to the prior period | —% | ||||
| Reported sales percent change, adjusted for impact of divestitures | 10% | ||||
| Less: Foreign currency translation | 1% | ||||
| Less: Acquisitions | —% | ||||
| Less: Other | —% | ||||
| Organic sales percent change | 9% | ||||
| Process Automation and Technology | |||||
| Reported sales percent change | 4% | ||||
| Less: Impact of divestitures to the prior period | —% | ||||
| Reported sales percent change, adjusted for impact of divestitures | 4% | ||||
| Less: Foreign currency translation | —% | ||||
| Less: Acquisitions | 5% | ||||
| Less: Other | —% | ||||
| Organic sales percent change | (1)% | ||||
| Industrial Automation | |||||
| Reported sales percent change | (5)% | ||||
| Less: Impact of divestitures to the prior period | (9)% | ||||
| Reported sales percent change, adjusted for impact of divestitures | 4% | ||||
| Less: Foreign currency translation | —% | ||||
| Less: Acquisitions | —% | ||||
| Less: Other | —% | ||||
| Organic sales percent change | 4% | ||||
| Aerospace Technologies | |||||
| Reported sales percent change | 5% | ||||
| Less: Impact of divestitures to the prior period | —% | ||||
| Reported sales percent change, adjusted for impact of divestitures | 5% | ||||
| Less: Foreign currency translation | —% | ||||
| Less: Acquisitions | —% | ||||
| Less: Other | —% | ||||
| Organic sales percent change | 5% | ||||
| 1 | Includes the financial results of the Honeywell Aerospace business which will be reflected as discontinued operations in the third quarter. These financial results may differ from Aerospace Technologies financial information due to the perimeter of the transaction, allocation of Honeywell Technologies corporate costs, and treatment of intracompany transactions, among other items, for both current and prior reporting periods. | |||||||
| Three Months Ended June 30, | |||||||||||||||||||||||
| 2026 | 2025 | ||||||||||||||||||||||
| Honeywell | Less: Separation Adjustments1 | Honeywell Technologies | Honeywell | Less: Separation Adjustments1 | Honeywell Technologies | ||||||||||||||||||
| Honeywell | |||||||||||||||||||||||
| Net sales | $ | 9,719 | $ | 4,532 | $ | 5,187 | $ | 9,322 | $ | 4,304 | $ | 5,018 | |||||||||||
| Less: Quantinuum | 5 | — | 5 | 2 | — | 2 | |||||||||||||||||
| Segment sales | $ | 9,714 | $ | 5,182 | $ | 9,320 | $ | 5,016 | |||||||||||||||
| 1 | Includes the financial results of the Honeywell Aerospace business which will be reflected as discontinued operations in the third quarter. These financial results may differ from Aerospace Technologies financial information due to the perimeter of the transaction, allocation of Honeywell Technologies corporate costs, and treatment of intracompany transactions, among other items, for both current and prior reporting periods. | |||||||
| Twelve Months Ended December 31, 2025 | |||||||||||
| Honeywell | Less: Separation Adjustments1 | Honeywell Technologies | |||||||||
| Honeywell | |||||||||||
| Net sales | $ | 37,442 | $ | 17,497 | $ | 19,945 | |||||
Less: Quantinuum | 30 | — | 30 | ||||||||
Segment sales | $ | 37,412 | $ | 19,915 | |||||||
| 1 | Includes the financial results of the Honeywell Aerospace business which will be reflected as discontinued operations in the third quarter. These financial results may differ from Aerospace Technologies financial information due to the perimeter of the transaction, allocation of Honeywell Technologies corporate costs, and treatment of intracompany transactions, among other items, for both current and prior reporting periods. | |||||||
| Three Months Ended June 30, | |||||||||||||||||||||||
| 2026 | 2025 | ||||||||||||||||||||||
| Honeywell | Less: Separation Adjustments1 | Honeywell Technologies | Honeywell | Less: Separation Adjustments1 | Honeywell Technologies | ||||||||||||||||||
| Operating income | $ | 1,737 | $ | 1,075 | $ | 662 | $ | 1,843 | $ | 1,177 | $ | 666 | |||||||||||
Stock compensation expense2 | 51 | 15 | 36 | 55 | 10 | 45 | |||||||||||||||||
Repositioning, Other3,4 | 100 | 26 | 74 | 42 | 14 | 28 | |||||||||||||||||
Pension and other postretirement service costs5 | 13 | 3 | 10 | 14 | 4 | 10 | |||||||||||||||||
Amortization of acquisition-related intangibles6 | 116 | 24 | 92 | 132 | 19 | 113 | |||||||||||||||||
Acquisition-related costs7 | 3 | — | 3 | (7) | — | (7) | |||||||||||||||||
Divestiture-related costs8 | 112 | 112 | — | — | — | — | |||||||||||||||||
ERP implementation costs2 | 5 | — | 5 | — | — | — | |||||||||||||||||
| Impairment of assets held for sale | 48 | — | 48 | — | — | — | |||||||||||||||||
Loss on Quantinuum8 | 55 | — | 55 | 49 | — | 49 | |||||||||||||||||
| Segment profit | $ | 2,240 | $ | 985 | $ | 2,128 | $ | 904 | |||||||||||||||
| Operating income | $ | 1,737 | $ | 662 | $ | 1,843 | $ | 666 | |||||||||||||||
| ÷ Segment sales | 9,714 | 5,182 | 9,320 | 5,016 | |||||||||||||||||||
| Operating income margin % | 17.9 | % | 12.8 | % | 19.8 | % | 13.3 | % | |||||||||||||||
| Segment profit | $ | 2,240 | $ | 985 | $ | 2,128 | $ | 904 | |||||||||||||||
| ÷ Segment sales | 9,714 | 5,182 | 9,320 | 5,016 | |||||||||||||||||||
| Segment profit margin % | 23.1 | % | 19.0 | % | 22.8 | % | 18.0 | % | |||||||||||||||
| 1 | Includes the financial results of the Honeywell Aerospace business which will be reflected as discontinued operations in the third quarter. These financial results may differ from Aerospace Technologies financial information due to the perimeter of the transaction, allocation of Honeywell Technologies corporate costs, and treatment of intracompany transactions, among other items, for both current and prior reporting periods. | |||||||
| 2 | Included in Selling, general and administrative expenses. | |||||||
| 3 | Includes repositioning, asbestos, environmental expenses, equity income adjustment, and other charges. | |||||||
| 4 | Included in Cost of products and services sold and Selling, general and administrative expenses. | |||||||
| 5 | Included in Cost of products and services sold, Research and development expenses, and Selling, general and administrative expenses. | |||||||
| 6 | Included in Cost of products and services sold. | |||||||
| 7 | Included in Cost of products and services sold. Includes acquisition-related fair value adjustments to inventory. | |||||||
| 8 | Included in Research and development expenses and Selling, general and administrative expenses. | |||||||
| 9 | Includes consolidated losses of Quantinuum prior to the deconsolidation of the Company’s investment in Quantinuum, which does not meet the definition of an operating segment. Included in Net sales, Cost of products and services sold, Research and development expenses, and Selling, general and administrative expenses. | |||||||
| Twelve Months Ended December 31, | |||||||||||
| 2025 | |||||||||||
| Honeywell | Less: Separation Adjustments1 | Honeywell Technologies | |||||||||
| Operating income | $ | 5,573 | $ | 4,402 | $ | 1,171 | |||||
Stock compensation expense2 | 196 | 43 | 153 | ||||||||
Repositioning, Other3,4 | 675 | 285 | 390 | ||||||||
Pension and other postretirement service costs5 | 73 | 16 | 57 | ||||||||
Amortization of acquisition-related intangibles6 | 570 | 61 | 509 | ||||||||
Acquisition-related costs7 | 2 | — | 2 | ||||||||
Indefinite-lived intangible asset impairment2 | 44 | — | 44 | ||||||||
| Impairment of goodwill | 724 | — | 724 | ||||||||
| Impairment of assets held for sale | 270 | — | 270 | ||||||||
Loss on Quantinuum8 | 187 | — | 187 | ||||||||
| Segment profit | $ | 8,314 | $ | 3,507 | |||||||
| Operating income | $ | 5,573 | $ | 1,171 | |||||||
| ÷ Segment sales | 37,412 | 19,915 | |||||||||
| Operating income margin % | 14.9 | % | 5.9 | % | |||||||
| Segment profit | $ | 8,314 | $ | 3,507 | |||||||
| ÷ Segment sales | 37,412 | 19,915 | |||||||||
| Segment profit margin % | 22.2 | % | 17.6 | % | |||||||
| 1 | Includes the financial results of the Honeywell Aerospace business which will be reflected as discontinued operations in the third quarter. These financial results may differ from Aerospace Technologies financial information due to the perimeter of the transaction, allocation of Honeywell Technologies corporate costs, and treatment of intracompany transactions, among other items, for both current and prior reporting periods. | |||||||
| 2 | Included in Selling, general and administrative expenses. | |||||||
| 3 | Includes repositioning, asbestos, environmental expenses, equity income adjustment, and other charges. | |||||||
| 4 | Included in Cost of products and services sold and Selling, general and administrative expenses. | |||||||
| 5 | Included in Cost of products and services sold, Research and development expenses, and Selling, general and administrative expenses. | |||||||
| 6 | Included in Cost of products and services sold. | |||||||
| 7 | Included in Cost of products and services sold. Includes acquisition-related fair value adjustments to inventory. | |||||||
| 8 | Includes consolidated losses of Quantinuum prior to the deconsolidation of the Company’s investment in Quantinuum, which does not meet the definition of an operating segment. Included in Net sales, Cost of products and services sold, Research and development expenses, and Selling, general and administrative expenses. | |||||||
| Three Months Ended June 30, | |||||||||||||||||||||||
| 2026 | 2025 | ||||||||||||||||||||||
| Honeywell | Less: Separation Adjustments1 | Honeywell Technologies | Honeywell | Less: Separation Adjustments1 | Honeywell Technologies | ||||||||||||||||||
Earnings per share of common stock from continuing operations - diluted2 | $ | 17.83 | $ | 1.18 | $ | 16.65 | $ | 4.33 | $ | 3.12 | $ | 1.21 | |||||||||||
Pension income3 | (0.40) | (0.19) | (0.21) | (0.21) | (0.18) | (0.03) | |||||||||||||||||
Amortization of acquisition-related intangibles4 | 0.28 | 0.06 | 0.22 | 0.31 | 0.04 | 0.27 | |||||||||||||||||
Acquisition-related costs5 | 0.02 | — | 0.02 | — | — | — | |||||||||||||||||
Divestiture-related costs6 | 1.69 | 1.43 | 0.26 | 0.14 | (0.03) | 0.17 | |||||||||||||||||
Debt restructuring costs7 | 0.10 | 0.09 | 0.01 | — | — | — | |||||||||||||||||
ERP implementation costs8 | 0.01 | — | 0.01 | — | — | — | |||||||||||||||||
Impairment of assets held for sale9 | 0.11 | — | 0.11 | — | — | — | |||||||||||||||||
Loss on sale of business10 | — | — | — | 0.09 | — | 0.09 | |||||||||||||||||
Impact of Russia-Ukraine conflict11 | 0.02 | — | 0.02 | — | — | — | |||||||||||||||||
Gain on deconsolidation of Quantinuum12 | (15.87) | — | (15.87) | — | — | — | |||||||||||||||||
Equity loss of Quantinuum13 | 0.65 | — | 0.65 | — | — | — | |||||||||||||||||
Loss on Quantinuum14 | 0.08 | — | 0.08 | 0.06 | — | 0.06 | |||||||||||||||||
| Adjusted earnings per share of common stock from continuing operations - diluted | $ | 4.52 | $ | 1.95 | $ | 4.72 | $ | 1.77 | |||||||||||||||
| 1 | Includes the financial results of the Honeywell Aerospace business which will be reflected as discontinued operations in the third quarter. These financial results may differ from Aerospace Technologies financial information due to the perimeter of the transaction, allocation of Honeywell Technologies corporate costs, and treatment of intracompany transactions, among other items, for both current and prior reporting periods. | |||||||
| 2 | For the three months ended June 30, 2026 and 2025, adjusted earnings per share utilizes weighted average shares of 318.6 million and 320.5 million, respectively. Per share amounts have been adjusted to reflect the reverse stock split, which took effect June 29, 2026. | |||||||
| 3 | For the three months ended June 30, 2026 and 2025, pension income was $129 million and $65 million, net of tax expense of $39 million and $20 million, respectively. For the three months ended June 30, 2026 and 2025, pension income for Honeywell Technologies was $68 million and $8 million, net of tax expense of $21 million and $3 million, respectively. | |||||||
| 4 | For the three months ended June 30, 2026 and 2025, acquisition-related intangibles amortization includes $89 million and $100 million, net of tax benefit of $27 million and $32 million, respectively. For the three months ended June 30, 2026 and 2025, acquisition-related intangibles amortization for Honeywell Technologies includes $71 million and $86 million, net of tax benefit of $21 million and $27 million, respectively. | |||||||
| 5 | For the three months ended June 30, 2026, the adjustment for acquisition-related costs, which is principally comprised of third-party transaction and integration costs was $6 million, net of tax benefit of $2 million. | |||||||
| 6 | For the three months ended June 30, 2026 and 2025, the adjustment for divestiture-related costs, which is principally comprised of third-party transaction, separation and simplification costs, was $537 million and $44 million, net of tax benefit of $296 million and $14 million, respectively. For the three months ended June 30, 2026 and 2025, the adjustment for divestiture-related costs for Honeywell Technologies, was $82 million and $54 million, net of tax benefit of $213 million and tax expense of $14 million, respectively. | |||||||
| 7 | For the three months ended June 30, 2026, the adjustment for debt restructuring costs was $31 million, net of tax benefit of $10 million. For the three months ended June 30, 2026, the adjustment for debt restructuring costs for Honeywell Technologies was $2 million, without tax benefit. | |||||||
| 8 | For the three months ended June 30, 2026, the adjustment for ERP implementation costs was $4 million, net of tax benefit of $1 million. | |||||||
| 9 | For the three months ended June 30, 2026, the impairment charge of assets held for sale was $36 million, net of tax benefit of $12 million. | |||||||
| 10 | For the three months ended June 30, 2025, the loss on sale of personal protection equipment business was $28 million, net of tax benefit of $2 million. | |||||||
| 11 | For the three months ended June 30, 2026, the adjustment for Russian-related charges was a $6 million expense, net of tax benefit of $2 million, due to the settlement of a contractual dispute associated with the Company’s suspension and wind down activities in Russia. | |||||||
| 12 | For the three months ended June 30, 2026, the adjustment is $5,057 million, net of tax expense of $1,572. | |||||||
| 13 | For the three months ended June 30, 2026, the adjustment for equity losses on Quantinuum is $207 million, net of tax benefit of $58 million. | |||||||
| 14 | Includes consolidated losses of Quantinuum prior to the deconsolidation of the Company’s investment in Quantinuum, which does not meet the definition of an operating segment. For the three months ended June 30, 2026 and 2025, the net income adjustment for Quantinuum was $52 million and $40 million, net of tax benefit of $16 million and $11 million, respectively. The net adjustment also reflects an adjustment to NCI of $25 million and $20 million, respectively, for the three months ended June 30, 2026 and 2025. | |||||||
| Twelve Months Ended December 31, | |||||||||||||||||
| 2025 | 2026(E) | ||||||||||||||||
| Honeywell | Less: Separation Adjustments1 | Honeywell Technologies | Honeywell Technologies | ||||||||||||||
Earnings per share of common stock from continuing operations - diluted2 | $ | 13.88 | $ | 10.64 | $ | 3.24 | $21.05 - $21.35 | ||||||||||
Pension income3 | (0.91) | (0.78) | (0.13) | No Forecast | |||||||||||||
Amortization of acquisition-related intangibles4 | 1.34 | 0.14 | 1.20 | 1.10 | |||||||||||||
Acquisition-related costs5 | 0.11 | — | 0.11 | 0.06 | |||||||||||||
Divestiture-related costs6 | 1.43 | 0.62 | 0.81 | No Forecast | |||||||||||||
Debt restructuring costs7 | — | — | — | 0.72 | |||||||||||||
ERP implementation costs8 | — | — | — | 0.06 | |||||||||||||
Impairment of assets held for sale9 | 0.65 | — | 0.65 | 0.74 | |||||||||||||
Indefinite-lived intangible asset impairment10 | 0.14 | — | 0.14 | — | |||||||||||||
Impairment of goodwill11 | 2.25 | — | 2.25 | — | |||||||||||||
(Gain) loss on sale of business12 | 0.09 | — | 0.09 | (0.02) | |||||||||||||
Gain related to Resideo indemnification and reimbursement agreement termination13 | (2.50) | — | (2.50) | — | |||||||||||||
Adjustment to estimated future environmental liabilities14 | 0.50 | 0.43 | 0.07 | — | |||||||||||||
Loss on settlement of divestiture of asbestos liabilities15 | 0.35 | — | 0.35 | — | |||||||||||||
Flexjet-related litigation matters16 | 0.95 | 0.95 | — | — | |||||||||||||
Impact of Russia-Ukraine conflict17 | — | — | — | 0.02 | |||||||||||||
Gain on deconsolidation of Quantinuum18 | — | — | — | (15.85) | |||||||||||||
Equity loss of Quantinuum19 | — | — | — | No Forecast | |||||||||||||
Loss on Quantinuum20 | 0.18 | — | 0.18 | 0.17 | |||||||||||||
| Adjusted earnings per share of common stock from continuing operations - diluted | $ | 18.46 | $ | 6.46 | $8.05 - 8.35 | ||||||||||||
| 1 | Includes the financial results of the Honeywell Aerospace business which will be reflected as discontinued operations in the third quarter. These financial results may differ from Aerospace Technologies financial information due to the perimeter of the transaction, allocation of Honeywell Technologies corporate costs, and treatment of intracompany transactions, among other items, for both current and prior reporting periods. | |||||||
| 2 | For the twelve months ended December 31, 2025, adjusted earnings per share utilizes weighted average shares of 321.4 million. For the twelve months ended December 31, 2026, expected earnings per share utilizes weighted average shares of approximately 319 million. Per share amounts have been adjusted to reflect the reverse stock split, which took effect June 29, 2026. | |||||||
| 3 | For the twelve months ended December 31, 2025, pension income was $291 million, net of tax expense of $89 million. For the twelve months ended December 31, 2025, pension income for Honeywell Technologies was $40 million, net of tax expense of $25 million. | |||||||
| 4 | For the twelve months ended December 31, 2025, acquisition-related intangibles amortization includes $432 million, net of tax benefit of $138 million. For the twelve months ended December 31, 2025, acquisition-related intangibles amortization for Honeywell Technologies includes $386 million, net of tax benefit of $123 million. For the twelve months ended December 31, 2026, the expected adjustment for acquisition-related intangibles amortization includes approximately $315 million, net of tax benefit of approximately $70 million. | |||||||
| 5 | For the twelve months ended December 31, 2025, the adjustment for acquisition-related costs, which is principally comprised of third-party transaction and integration costs and acquisition-related fair value adjustments to inventory, was $35 million, net of tax benefit of $10 million. For the twelve months ended December 31, 2026, the expected adjustment for acquisition-related costs, which is principally comprised of third-party transaction and integration costs, is approximately $20 million, net of tax benefit of approximately $5 million. | |||||||
| 6 | For the twelve months ended December 31, 2025, the adjustment for divestiture-related costs, which is principally comprised of third-party transaction costs, was $460 million, net of tax benefit of $61 million. For the twelve months ended December 31, 2025, the adjustment for divestiture-related costs for Honeywell Technologies was $262 million, net of tax expense of $31 million. | |||||||
| 7 | For the twelve months ended December 31, 2026, the expected adjustment for debt restructuring costs is $257 million, net of tax benefit of $80 million. For the twelve months ended December 31, 2026, the expected adjustment for debt restructuring costs excluding spin-off impact is $228 million, net of tax benefit of $70 million. | |||||||
| 8 | For the twelve months ended December 31, 2026, the expected adjustment for ERP implementation costs is approximately $20 million, net of tax benefit of approximately $5 million. | |||||||
| 9 | For the twelve months ended December 31, 2025, the impairment charge of assets held for sale was $209 million, net of tax benefit of $61 million. For the twelve months ended December 31, 2026, the expected impairment charge of assets held for sale is $236 million, net of tax benefit of $75 million. | |||||||
| 10 | For the twelve months ended December 31, 2025, the impairment charge of indefinite-lived intangible assets associated with the Industrial Automation reportable segment was $44 million, without tax benefit. | |||||||
| 11 | For the twelve months ended December 31, 2025, the impairment charge of goodwill associated with the Industrial Automation reportable segment was $724 million, without tax benefit. | |||||||
| 12 | For the twelve months ended December 31, 2025, the adjustment for loss on sale of the personal protective equipment business was $28 million, net of tax benefit of $2 million. For the twelve months ended December 31, 2026, the expected gain on sale of personal protection equipment business is $5 million, net of tax expense of $1 million. | |||||||
| 13 | For the twelve months ended December 31, 2025, the gain related to the Resideo indemnification and reimbursement agreement termination was $802 million, without tax expense. | |||||||
| 14 | In the twelve months ended December 31, 2025, the Company enhanced its process for estimating environmental liabilities at sites undergoing active remediation, which led to earlier recognition of the estimated probable liabilities and an increase to estimated environmental liabilities. For the twelve months ended December 31, 2025, the adjustment to increase environmental liabilities was $161 million, net of tax benefit of $50 million. For the twelve months ended December 31, 2025, the adjustment to increase environmental liabilities for Honeywell Technologies was $22 million, net of tax benefit of $7 million. | |||||||
| 15 | For the twelve months ended December 31, 2025, the adjustment for loss on settlement of divestiture of asbestos liabilities was $112 million, net of tax benefit of $36 million. | |||||||
| 16 | For the twelve months ended December 31, 2025, the adjustment for the Flexjet-related litigation matters was $302 million, net of tax benefit of $71 million. Management considers the nature and significance of these litigation matters to be unusual and not indicative of the Company's ongoing performance. | |||||||
| 17 | For the twelve months ended December 31, 2026, the expected adjustment for Russian-related charges was a $6 million expense, net of tax benefit of $2 million, due to the settlement of a contractual dispute associated with the Company’s suspension and wind down activities in Russia. | |||||||
| 18 | For the twelve months ended December 31, 2026, the expected adjustment is $5,057 million, net of tax expense of $1,572. | |||||||
| 19 | The equity losses of Quantinuum are based on our proportionate share of Quantinuum's earnings or losses, which are outside of the Company's control. We therefore do not include an estimate for these amounts. | |||||||
| 20 | Includes consolidated losses of Quantinuum prior to the deconsolidation of the Company’s investment in Quantinuum, which does not meet the definition of an operating segment. For the twelve months ended December 31, 2025, the net income adjustment for Quantinuum was $135 million, net of tax benefit of $43 million. The net adjustment also reflects an adjustment to NCI of $78 million for the twelve months ended December 31, 2025. | |||||||
| Three Months Ended June 30, 2026 | Three Months Ended June 30, 2025 | Twelve Months Ended December 31, 2026(E) | |||||||||||||||||||||||||||
| Honeywell | Less: Separation Adjustments1 | Honeywell Technologies | Honeywell | Less: Separation Adjustments1 | Honeywell Technologies | Honeywell Technologies | |||||||||||||||||||||||
| Cash provided by operating activities from continuing operations | $ | 1,276 | $ | 713 | $ | 563 | $ | 1,064 | $ | 877 | $ | 187 | $1.9 - $2.2 | ||||||||||||||||
| Capital expenditures | (315) | (128) | (187) | (226) | (118) | (108) | ~(0.6) | ||||||||||||||||||||||
| Spin-off and separation-related cost payments | 260 | 211 | 49 | 7 | 5 | 2 | ~0.4 | ||||||||||||||||||||||
| Quantinuum | 31 | — | 31 | 33 | — | 33 | ~0.1 | ||||||||||||||||||||||
| Free cash flow | $ | 1,252 | $ | 456 | $ | 878 | $ | 114 | ~1.8 - $2.1 | ||||||||||||||||||||
| 1 | Includes the financial results of the Honeywell Aerospace business which will be reflected as discontinued operations in the third quarter. These financial results may differ from Aerospace Technologies financial information due to the perimeter of the transaction, allocation of Honeywell Technologies corporate costs, and treatment of intracompany transactions, among other items, for both current and prior reporting periods. | |||||||